News
Hosted on MSN6mon
Failure in a CAR T cell trial could unlock multiple treatments for acute myeloid leukemiaThe current study evaluates the safety and efficacy of CART-123 in adult patients with relapsed or refractory AML. The study enrolled 22 patients, with 20 confirmed eligible. The median age of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback